Go to contents
Go to menu
°Ë»ö¾î ÀÔ·Â
Ȩ
·Î±×ÀÎ
Áñ°Üã±âÃß°¡
ENGLlSH
°í±Þ°Ë»ö
Àú³Îº°°Ë»ö
¿ø¹®Á¦°ø Àú³Îº°°Ë»ö
¿¬±¸ºÐ¾ßº° °Ë»ö
ÇÐȸ/Çùȸ Á¤º¸
Àú³Î Á¤º¸
Àú³Î Åõ°í ±ÔÁ¤
KMbase ¼Ò°³
°øÁö»çÇ×
¾÷µ¥ÀÌÆ® Á¤º¸
³» Á¤º¸
ÀúÀå ³í¹®
°ü½ÉºÐ¾ß ³í¹®
°ü½ÉÇÐȸ/ÇмúÁ¤º¸
¿ø¹®½Åû
°ü½ÉºÐ¾ß °ü¸®
½ºÅ©¸³Æ® ȯ°æ¿¡¼ Áö¿øµË´Ï´Ù.
³í¹®°Ë»ö
°í±Þ°Ë»ö
Àú³Îº°°Ë»ö
¿ø¹®Á¦°ø Àú³Î°Ë»ö
¿¬±¸ºÐ¾ßº° °Ë»ö
SITE LINK
PubMed
Google Scholar
NDSL
KISTI
KoreaMed
RISS
MEDLIS
Cross Check
½ÅÀÇ·á±â¼úÆò°¡ º¸°í¼
( NECA Report )
: °Ë»ö°á°ú :
1
  
°Ë»ö°á°ú¸ðµÎ¼±ÅÃ
1
Ç×-Infliximab Ç×ü Á¤·® [È¿¼Ò°áÇո鿪ÈíÂø¹ý]
Anti-Infliximab Antibody Quantitative [Enzyme-Linked Immunosorbent Assay]
½Åä¹Î ( Shin Chae-Min )
¸ðÁø¾Æ ( Mo Jin-A ), Á¶¹ÎÁ¤, ¹Ú±Ù¿µ ( Park Keun-Young ), ±è¼¼Èñ ( Kim Sei-Hee ), Àü¹ÌÇý ( Jeon Mi-Hye&nbs
...
½ÅÀÇ·á±â¼úÆò°¡ º¸°í¼
2019³â 1±Ç 46È£ 1 ~ 262